Brief: Erytech To Be Part Of EU-backed EVIDENCE Consortium
May 6 (Reuters) - ERYTECH PHARMA SA ERYP.PA :
* ANNOUNCED ON TUESDAY IT WILL BE PART OF EVIDENCE, A
PUBLIC-PRIVATE CONSORTIUM SUPPORTED BY EU
* THE EVIDENCE CONSORTIUM WILL EXPLORE HOW RED BLOOD CELLS
ARE
INFLUENCED BY THEIR EXTRA-CELLULAR ENVIRONMENT
* EU HAS PROVIDED 4 MILLION EUROS OF FUNDING FOR EVIDENCE
PROJECT
AS PART OF MARIE SKLODOWSKA-CURIE ACTIONS PROGRAM
Source text for Eikon: urn:newsml:reuters.com:*:nGNXbkC0l9
Further company coverage: ERYP.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure